glp-1 ibd drugs calm inflammation beyond diabetes and weight loss GLPs as novel therapeutic options

The structure of the GLP-1 receptor complexed with its ligand offers insight into the mechanism of class B G-protein-coupled receptor activation.

The first cohort included 6696 patients who started GLP-1 receptor agonists and added on SGLT-2 inhibitors, and the second included 8942 patients who started SGLT-2 inhibitors and added on GLP-1 receptor agonists

Here's what to know

A strategic GLP-1 playbook covering market size, regulation, competitors, consumer behavior, product trends, funding, and GTM strategy in healthtech

Busy pros craving restorative sleep

However, they've still got to pay for the weight-loss drug itself.